.png){kind=small}
.png){kind=small}
BackTable / MSK / Podcast / Episode #54
Managing Sarcomas: A Multidisciplinary Approach
with Dr. Yvette Ho and Dr. Jessica Jones
In this episode of The Back Table MSK Podcast, Dr. Alexa Levey discusses the importance of multidisciplinary treatment planning for sarcomas with Dr. Yvette Ho and Dr. Jessica Jones.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, July 16). Ep. 54 – Managing Sarcomas: A Multidisciplinary Approach [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Yvette Ho
Dr. Yvette Ho is a fellowship-trained orthopedic surgeon specializing in orthopedic oncology with Atlantic Medical Group.
Dr. Jessica Jones
Dr. Jessica Trevino Jones is a board certified internist and oncologist at the University of Texas Health Science Center in San Antonia, Texas.
Dr. Alexa Levey
Dr. Alexa Levey is an interventional radiologist, interventional pain proceduralist, and assistant clinical professor in Houston, Texas.
Synopsis
The conversation explores the necessity of a multidisciplinary approach and the challenges associated with managing both osseous and soft tissue sarcomas. Dr. Jones highlights recent advancements in precision medicine, including a novel drug, nirogacesta, for desmoid tumors. Dr. Ho addresses common misconceptions surrounding desmoid tumors, emphasizing their potential for significant tissue destruction, and shares insights from her experience in limb salvage surgery. Dr. Levey discusses the considerations involved in needle biopsy and presents case studies where cryoablation effectively reduced desmoid tumor sizes.
The doctors also discuss strategies for managing nociceptive and mechanical pain, such as intrathecal pain pumps, radiation therapy, and kyphoplasty.
Timestamps
00:00 - Introduction
03:51 - Challenges in Sarcoma Management
13:06 - Precision Medicine in Treatment Planning
16:44 - The Role of Biopsy
20:51 - The Importance of Specialized Oncology Care
25:13 - Collaboration Throughout Treatment Course
31:03 - Cryoablation and Case Studies
35:13 - New Drug Development for Desmoid Tumors
39:06 - Limb Salvage Considerations
41:13 - Metastasis, Recurrence, and Pain Management
49:57 - Final Thoughts
Resources
OGSIVEO (Nirogacestat):
https://www.ogsiveo.com/
Bone cement: Serious adverse events, some with fatal outcome, associated with the use of bone cements for vertebroplasty, kyphoplasty and sacroplasty include myocardial infarction, cardiac arrest, cerebrovascular accident, pulmonary embolism and cardiac embolism. Although it is rare, some adverse events have been known to occur beyond one year post-operatively. Additional risks exist with the use of bone cement. Please see the IFU for a complete list of potential risks.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
